Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain.
González-Larriba JL, Serrano S, Alvarez-Mon M, Camacho F, Casado MA, Díaz-Pérez JL, Díaz-Rubio E, Fosbrook L, Guillem V, López-López JJ, Moreno-Nogueira JA, Toribio J.
González-Larriba JL, et al. Among authors: camacho f.
Eur J Cancer. 2000 Dec;36(18):2344-52. doi: 10.1016/s0959-8049(00)00304-x.
Eur J Cancer. 2000.
PMID: 11094308
Clinical Trial.